UTEP Faculty Profiles

Main Content

Priscila Silva Grijo Farani

Research Assistant Professor
Biological Sciences

Office Building: Bioscience Research Building
Office Room: 5.122
Phone:
Email: psilvagrij@utep.edu

Bio

Translational scientist specializing in molecular biology, immunology, and biomarker discovery for neglected tropical diseases, with a focus on Chagas disease and multi-omics approaches to improve global health outcomes.

Awards and Honors

Founder & Chair, The University of Texas at El Paso Postdoctoral Association - The University of Texas at El Paso (01/01/2024)
Co-chair Of Gordon Research Seminars in Tropical Infectious Diseases - Gordon Research Conferences (04/01/2023)
Oswaldo Cruz Best Dissertation Award - Oswaldo Cruz Institute - FIOCRUZ, Brazil (09/01/2022)
PrInt CAPES Ph.D. Scholarship - Coordination for the Improvement of Higher Education Personnel) (09/01/2019)

Education

No info available.

Publications

Utility of Magnetic Bead-Based Automated DNA Extraction to Improve Chagas Disease Molecular Diagnosis International Journal of Molecular Sciences (2025), Priscila Silva Grijo Farani.
Treatments and the perspectives of developing a vaccine for Chagas disease Vaccines (2024), Priscila Silva Grijo Farani.
Establishment of a murine model of congenital toxoplasmosis and validation of a qPCR assay to assess the parasite load in maternal and fetal tissues Frontiers in Microbiology (2023), Priscila Silva Grijo Farani.
Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy PLoS neglected tropical diseases (2023), Priscila Silva Grijo Farani.
Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts Scientific Reports (2022), Priscila Silva Grijo Farani.
Potato apyrase reduces granulomatous area and increases presence of multinucleated giant cells in murine schistosomiasis Parasitology International (2021), Priscila Silva Grijo Farani.
Schistosoma mansoni venom allergen-like protein 6 (SmVAL6) maintains tegumental barrier function International Journal for Parasitology (2021), Priscila Silva Grijo Farani.
Treatment with suboptimal dose of benznidazole mitigates immune response molecular pathways in mice with chronic chagas cardiomyopathy Frontiers in Cellular and Infection Microbiology (2021), Priscila Silva Grijo Farani.

Presentations

Safety and efficacy of novel Benznidazole and Nifurtimox regimens in chronic Chagas disease and early biomarkers for assessing treatment outcomes (2025), Volume Lucca, Italy, Priscila Silva Grijo Farani.
Isolation and characterization of α-Gal-containing extracellular vesicles from Trypanosoma cruzi: Unveiling new biomarkers for Chagas disease (2024), Volume New Orleans, Priscila Silva Grijo Farani.
Rationally Designed Prophylactic Glycan- and Peptide-Based Vaccines Prevent Cardiomyopathy by Modulating the Immunometabolism in a Nonhuman Primate Model of Chagas Disease (2024), Volume Caxambu, Priscila Silva Grijo Farani.
Rationally designed, prophylactic glycan- and peptide-based vaccines prevent cardiomyopathy development in a nonhuman primate model of Chagas Disease (2024), Volume San Antonio, Priscila Silva Grijo Farani.
Inflammation, immune response and metabolomic modulation induced by prophylactic glycan- and peptide-based vaccines in Papio hamadryas baboon model of Chagas disease (2024), Volume Atlanta, Priscila Silva Grijo Farani.
Rationally designed, prophylactic glycan- and peptide-based vaccines prevent cardiomyopathy development in a nonhuman primate model of Chagas disease (2024), Volume El Paso, Priscila Silva Grijo Farani.
Prophylactic glycan- and peptide-based vaccines elicit a protective immune response, miRNA differential expression, and metabolomic modulation in a nonhuman primate model of Chagas disease (2023), Volume Galveston, Priscila Silva Grijo Farani.

Grants

No info available.

Current/Future Courses

Term	Course	Section
Fall 2025	ESE 6296 - Doctoral Research	18557
Fall 2025	PHAR 6470 - ISBP IIA1	12925
Fall 2025	PHAR 6475 - ISBP IIIA2	12900
Fall 2025	PHAR 6203 - Pathophysiology & Immunology	16563

Past Courses

No info available.

Course Evaluations

No info available.

Bio

Awards and Honors

Founder & Chair, The University of Texas at El Paso Postdoctoral Association - The University of Texas at El Paso (01/01/2024)
Co-chair Of Gordon Research Seminars in Tropical Infectious Diseases - Gordon Research Conferences (04/01/2023)
Oswaldo Cruz Best Dissertation Award - Oswaldo Cruz Institute - FIOCRUZ, Brazil (09/01/2022)
PrInt CAPES Ph.D. Scholarship - Coordination for the Improvement of Higher Education Personnel) (09/01/2019)

No info available.

Publications

Utility of Magnetic Bead-Based Automated DNA Extraction to Improve Chagas Disease Molecular Diagnosis International Journal of Molecular Sciences (2025), Priscila Silva Grijo Farani.
Treatments and the perspectives of developing a vaccine for Chagas disease Vaccines (2024), Priscila Silva Grijo Farani.
Establishment of a murine model of congenital toxoplasmosis and validation of a qPCR assay to assess the parasite load in maternal and fetal tissues Frontiers in Microbiology (2023), Priscila Silva Grijo Farani.
Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy PLoS neglected tropical diseases (2023), Priscila Silva Grijo Farani.
Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts Scientific Reports (2022), Priscila Silva Grijo Farani.

Presentations

Safety and efficacy of novel Benznidazole and Nifurtimox regimens in chronic Chagas disease and early biomarkers for assessing treatment outcomes (2025), Volume Lucca, Italy, Priscila Silva Grijo Farani.
Isolation and characterization of α-Gal-containing extracellular vesicles from Trypanosoma cruzi: Unveiling new biomarkers for Chagas disease (2024), Volume New Orleans, Priscila Silva Grijo Farani.
Rationally Designed Prophylactic Glycan- and Peptide-Based Vaccines Prevent Cardiomyopathy by Modulating the Immunometabolism in a Nonhuman Primate Model of Chagas Disease (2024), Volume Caxambu, Priscila Silva Grijo Farani.
Rationally designed, prophylactic glycan- and peptide-based vaccines prevent cardiomyopathy development in a nonhuman primate model of Chagas Disease (2024), Volume San Antonio, Priscila Silva Grijo Farani.
Inflammation, immune response and metabolomic modulation induced by prophylactic glycan- and peptide-based vaccines in Papio hamadryas baboon model of Chagas disease (2024), Volume Atlanta, Priscila Silva Grijo Farani.

No info available.

Current/Future Courses

Term

Fall 2025

Course

ESE 6296 - Doctoral Research

Section

18557

Syllabus

Term

Fall 2025

Course

PHAR 6470 - ISBP IIA1

Section

12925

Syllabus

Term

Fall 2025

Course

PHAR 6475 - ISBP IIIA2

Section

12900

Syllabus

Term

Fall 2025

Course

PHAR 6203 - Pathophysiology & Immunology

Section

16563

Syllabus

Past Courses

No info available.

FACULTY PROFILES

Quick Links

Priscila Silva Grijo Farani

FACULTY PROFILES

Priscila Silva Grijo Farani

Bio

Education

Scholarly and Creative Activity

Grants

Courses

Course Evaluations